Marker Therapeutics, Inc. (MRKR)
NASDAQ: MRKR · Real-Time Price · USD
3.100
+0.130 (4.38%)
Nov 22, 2024, 4:00 PM EST - Market closed
Marker Therapeutics Analyst Ratings
Total Analysts
1
Consensus Rating
Strong Buy
Price Target
$19.00
Upside
+512.90%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Maintains $11 → $19 | Strong Buy | Maintains | $11 → $19 | +512.90% | Oct 21, 2024 |
| Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Initiates $11 | Strong Buy | Initiates | $11 | +254.84% | Apr 30, 2024 |
| Roth Capital | Roth Capital | Strong Buy → Hold Downgrades $30 → $10 | Strong Buy → Hold | Downgrades | $30 → $10 | +222.58% | Feb 17, 2022 |
| Piper Sandler | Piper Sandler | Buy Initiates $60 | Buy | Initiates | $60 | +1,835.48% | Mar 25, 2021 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $60 | Buy | Initiates | $60 | +1,835.48% | Mar 19, 2021 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $60 | Buy | Initiates | $60 | +1,835.48% | Mar 18, 2021 |
| Piper Sandler | Piper Sandler | Buy → Hold Downgrades $50 → $25 | Buy → Hold | Downgrades | $50 → $25 | +706.45% | May 12, 2020 |
| Piper Sandler | Piper Sandler | Buy Maintains $100 → $60 | Buy | Maintains | $100 → $60 | +1,835.48% | Nov 13, 2019 |
| Roth Capital | Roth Capital | Strong Buy Initiates $100 | Strong Buy | Initiates | $100 | +3,125.81% | May 30, 2019 |